{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:13:13Z","timestamp":1793679193875,"version":"4.5.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neulet.2020.135078","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:43:16Z","timestamp":1590183796000},"page":"135078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-A\u03b2 load and cerebrospinal fluid A\u03b2 in a pilot study of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"731","author":[{"given":"Bryant","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veer Bala","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Doecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-820X","authenticated-orcid":false,"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2020.135078_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3233\/JAD-140843","article-title":"Biomarkers for preclinical alzheimer\u2019s disease","volume":"42","author":"Tan","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neulet.2020.135078_bib0010","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00018-019-03040-5","article-title":"Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer\u2019s disease pathogenesis","volume":"76","author":"Dhiman","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neulet.2020.135078_bib0015","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2967\/jnumed.116.185017","article-title":"Clinical use and utility of amyloid imaging","volume":"58","author":"Barthel","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-170773","article-title":"The past and the future of Alzheimer\u2019s disease fluid biomarkers","volume":"62","author":"Blennow","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neulet.2020.135078_bib0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jnnp-2019-321073","article-title":"CSF and blood Kallikrein-8: A. promising early biomarker for Alzheimer\u2019s disease","volume":"91","author":"Teuber-Hanselmann","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neulet.2020.135078_bib0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","article-title":"Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer\u2019s disease cerebrospinal fluid","volume":"18","author":"Lle\u00f3","year":"2019","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.neulet.2020.135078_bib0035","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neulet.2020.135078_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer\u2019s Disease: A Correlative Meta-Analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neulet.2020.135078_bib0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jocn.2018.09.031","article-title":"Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Kanata","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neulet.2020.135078_bib0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3233\/JAD-180025","article-title":"Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-\u03b2 Load and Cognitive Performance in Cognitively Normal Elderly Participants","volume":"63","author":"Chatterjee","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neulet.2020.135078_bib0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neulet.2020.135078_bib0060","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2020.135078_bib0065","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.neulet.2020.135078_bib0070","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2019-322493","article-title":"Genetic Frontotemporal Dementia Initiative, Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia","author":"van der Ende","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neulet.2020.135078_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.arr.2011.12.004","article-title":"Pentraxins and Alzheimer\u2019s disease: At the interface between biomarkers and pharmacological targets","volume":"11","author":"Osera","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neulet.2020.135078_bib0080","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1093\/cercor\/bhx046","article-title":"Neuronal and Peripheral Pentraxins Modify Glutamate Release and may Interact in Blood-Brain Barrier Failure","volume":"27","author":"Cummings","year":"2017","journal-title":"Cereb. Cortex."},{"key":"10.1016\/j.neulet.2020.135078_bib0085","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.12688\/f1000research.15095.1","article-title":"Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer\u2019s disease progression","volume":"7","author":"Begcevic","year":"2018","journal-title":"F1000Research."},{"key":"10.1016\/j.neulet.2020.135078_bib0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1515\/cclm-2019-0428","article-title":"Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer\u2019s disease","volume":"57","author":"Lim","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23798","article-title":"NPTX2 and cognitive dysfunction in Alzheimer\u2019s Disease","volume":"6","author":"Xiao","year":"2017","journal-title":"Elife."},{"key":"10.1016\/j.neulet.2020.135078_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-9-22","article-title":"Identification of longitudinally dynamic biomarkers in Alzheimer\u2019s disease cerebrospinal fluid by targeted proteomics","volume":"9","author":"Wildsmith","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2020.135078_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135365","article-title":"High resolution discovery proteomics reveals candidate disease progression markers of Alzheimer\u2019s disease in human cerebrospinal fluid","volume":"10","author":"Hendrickson","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.neulet.2020.135078_bib0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.21038","article-title":"Cerebrospinal fluid proteomic biomarkers for Alzheimer\u2019s disease","volume":"61","author":"Finehout","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2020.135078_bib0115","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/prca.200600999","article-title":"Identification and validation of novel CSF biomarkers for early stages of Alzheimer\u2019s disease","volume":"1","author":"Hu","year":"2007","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.neulet.2020.135078_bib0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"AIBL Research Group, The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int. Psychogeriatrics."},{"key":"10.1016\/j.neulet.2020.135078_bib0125","unstructured":"AIBL, (n.d.). https:\/\/aibl.csiro.au\/ (accessed April 27, 2020)."},{"key":"10.1016\/j.neulet.2020.135078_bib0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment - Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology."},{"key":"10.1016\/j.neulet.2020.135078_bib0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-150247","article-title":"Alzheimer\u2019s disease normative cerebrospinal fluid biomarkers validated in pet amyloid-\u03b2 characterized subjects from the australian imaging, biomarkers and lifestyle (AIBL) study","volume":"48","author":"Li","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neulet.2020.135078_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-015-0157-7","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology","volume":"7","author":"Rembach","year":"2015","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neulet.2020.135078_bib0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0155","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment a phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2020.135078_bib0160","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2967\/jnumed.112.114785","article-title":"Head-to-head comparison of11C-PiB and18F-AZD4694 (NAV4694) for \u03b2-amyloid imaging in aging and dementia","volume":"54","author":"Rowe","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0165","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.neulet.2020.135078_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: Standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neulet.2020.135078_bib0175","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2967\/jnumed.115.171595","article-title":"Standardized Expression of 18F-NAV4694 and 11C-PiB b-amyloid PET results with the centiloid scale","volume":"57","author":"Rowe","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2020.135078_bib0180","doi-asserted-by":"crossref","first-page":"P11","DOI":"10.1016\/j.jalz.2017.06.2275","article-title":"Determining the utility of PMOD image quantification software for processing [11C]PIB and [18F]flutemetamol images in a PET-only pipeline to generate SUVR for quantification on the centiloid scale","volume":"13","author":"Battle","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neulet.2020.135078_bib0185","first-page":"P25","article-title":"Conversion of amyloid quantitation with florbetapir SUVR to the centiloid scale","volume":"12","author":"Navitsky","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neulet.2020.135078_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer\u2019s disease","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neulet.2020.135078_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-019-0478-z","article-title":"Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers","volume":"11","author":"Salvad\u00f3","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neulet.2020.135078_bib0200","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.neuron.2015.02.020","article-title":"Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons","volume":"85","author":"Pelkey","year":"2015","journal-title":"Neuron."},{"key":"10.1016\/j.neulet.2020.135078_bib0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1523\/JNEUROSCI.2768-16.2016","article-title":"Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses","volume":"37","author":"Lee","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2020.135078_bib0210","doi-asserted-by":"crossref","first-page":"27311","DOI":"10.1074\/jbc.M111.227504","article-title":"Soluble oligomers of amyloid-\u03b2 peptide disrupt membrane trafficking of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction","volume":"286","author":"Mi\u00f1ano-Molina","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2020.135078_bib0215","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","article-title":"Amyloid \u03b2 oligomers induce Ca 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors","volume":"47","author":"Alberdi","year":"2010","journal-title":"Cell Calcium."},{"key":"10.1016\/j.neulet.2020.135078_bib0220","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1523\/JNEUROSCI.4604-11.2012","article-title":"NP1 regulates neuronal activity-dependent accumulation of BAX in mitochondria and mitochondrial dynamics","volume":"32","author":"Clayton","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2020.135078_bib0225","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neulet.2020.135078_bib0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.trci.2019.02.004","article-title":"Differential effects of neurodegeneration biomarkers on subclinical cognitive decline, Alzheimer\u2019s Dement","volume":"5","author":"Merluzzi","year":"2019","journal-title":"Transl. Res. Clin. Interv."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394020303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394020303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:34:09Z","timestamp":1759610049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394020303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"alternative-id":["S0304394020303487"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2020.135078","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-A\u03b2 load and cerebrospinal fluid A\u03b2 in a pilot study of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2020.135078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"135078"}}